Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)
National Institutes of Health
U.S. Department of Health and Human Services
NIH Consensus Development Conference: Diagnosing Gestational Diabetes Mellitus

Agenda

Monday, March 4, 2013

8:30 a.m. Opening Remarks
Alan E. Guttmacher, M.D.
Director
Office of the Director
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health
8:40 a.m. Charge to the Panel
David M. Murray, Ph.D.
Associate Director for Prevention
and Director of the Office of Disease Prevention
Office of the Director
National Institutes of Health
8:50 a.m. Conference Overview and Panel Activities
James Peter VanDorsten, M.D.
Panel and Conference Chairperson
Lawrence L. Hester, Jr. Professor
Division of Maternal-Fetal Medicine
Department of Obstetrics and Gynecology
Medical University of South Carolina
9:00 a.m. Overview of the Topic
Catherine Y. Spong, M.D.
Associate Director, Extramural Programs
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health
9:20 a.m. Epidemiology of Gestational Diabetes Mellitus
William M. Callaghan, M.D., M.P.H.
Chief
Maternal and Infant Health Branch
Division of Reproductive Health
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention
  1. What are the current screening and diagnostic approaches for gestational diabetes mellitus, what are the glycemic thresholds for each approach, and how were these thresholds chosen?
9:40 a.m. Current Diagnostic Methods and Thresholds of Gestational Diabetes Mellitus
Donald R. Coustan, M.D.
Professor of Obstetrics and Gynecology
Warren Alpert Medical School
Brown University
Division of Maternal-Fetal Medicine
Women & Infants Hospital of Rhode Island
  1. What are the effects of various gestational diabetes mellitus screening/ diagnostic approaches for patients, providers, and U.S. health care systems?
10:00 a.m. Comparative Benefits/Harms of Varying Diagnostic Thresholds of Gestational Diabetes Mellitus
Wanda Nicholson, M.D., M.P.H., M.B.A.
Director
Diabetes and Obesity Core
Center for Women’s Health Research
Associate Professor
Department of Obstetrics and Gynecology
The University of North Carolina School of Medicine
10:20 a.m. Discussion
  1. In the absence of treatment, how do health outcomes of mothers who meet various criteria for gestational diabetes mellitus and their offspring compare with those who do not?
10:40 a.m. Relative Hyperglycemia and Health Outcomes for Mother and Fetus
Evidence-based Practice Center
11:00 a.m. Relative Hyperglycemia and Health Outcomes for Mother
Patrick M. Catalano, M.D.
Professor
Reproductive Biology
Director
Center for Reproductive Health
MetroHealth Medical Center
Case Western Reserve University
11:20 a.m. Relative Hyperglycemia and Health Outcomes for Fetus
David J. Pettitt, M.D.
Senior Scientist
Sansum Diabetes Research Institute
11:40 a.m. Discussion
12:10 p.m. Lunch
  1. Does treatment modify the health outcomes of mothers who meet various criteria for gestational diabetes mellitus and their offspring?
1:30 p.m. Benefits of Treatment of Gestational Diabetes Mellitus on Maternal and Fetal Health Outcomes
Evidence-based Practice Center
1:50 p.m. Benefits of Treatment of Gestational Diabetes Mellitus on Maternal Health Outcomes
Mark B. Landon, M.D.
Richard L. Meiling Professor and Chair
Department of Obstetrics and Gynecology
The Ohio State University College of Medicine and
Wexner Medical Center
2:10 p.m. Benefits of Treatment of Gestational Diabetes Mellitus on Fetal/Infant Health Outcomes
Matthew W. Gilman, M.D., S.M.
Director
Obesity Prevention Program
Professor
Department of Population Medicine
Harvard Medical School
Harvard Pilgrim Health Care Institute
2:30 p.m. Discussion
  1. What are the harms of treating gestational diabetes mellitus, and do they vary by diagnostic approach?
3:00 p.m. Harms of Treatment of Gestational Diabetes Mellitus and Relationship to Diagnostic Threshold
Evidence-based Practice Center
3:20 p.m. Harms of Treatment of Gestational Diabetes Mellitus and Relationship to Diagnostic Threshold
Timothy Cundy, M.D.
Professor of Medicine
Faculty of Medical and Health Sciences
The University of Auckland
3:40 p.m. Economic Implications of Altering Gestational Diabetes Mellitus Diagnostic Criteria
Aaron B. Caughey, M.D., Ph.D., M.P.P., M.P.H.
Professor and Chair
Department of Obstetrics and Gynecology
Julie Neupert Stott Director
Center for Women’s Health
Oregon Health & Science University
4:00 p.m. Practice Implications of Altering Gestational Diabetes Mellitus Diagnostic Criteria
William H. Barth, Jr., M.D.
Chief
Division of Maternal Fetal Medicine
Obstetrics and Gynecology Service
Massachusetts General Hospital
Associate Professor of Obstetrics, Gynecology and
Reproductive Biology
Harvard Medical School
4:20 p.m. Discussion
5:00 p.m. Adjournment

Tuesday, March 5, 2013

  1. Given all of the above, what diagnostic approach(es) for gestational diabetes mellitus should be recommended, if any?
8:30 a.m. Review of Maternal Experience of Having Diabetes Mellitus in Pregnancy
Ilana R. Azulay Chertok, PhD, MSN, RN, IBCLC
Associate Professor
West Virginia University School of Nursing
8:50 a.m. Pro Status Quo
Brian M. Casey, M.D.
Gillette Professorship
Obstetrics and Gynecology
The University of Texas Southwestern Medical Center
9:10 a.m. Pro International Association of Diabetes and Pregnancy Study Group
Boyd E. Metzger, M.D.
Tom D. Spies Professor of Metabolism and Nutrition
Department of Medicine
Division of Endocrinology, Metabolism and Molecular Medicine
Northwestern University
Feinberg School of Medicine
9:30 a.m. Pro Alternative
Edmond A. Ryan, M.D.
Professor
Department of Medicine
Division of Endocrinology
University of Alberta
9:50 a.m. Discussion
11:00 a.m. Adjournment

Wednesday, March 6, 2013

9:00 a.m. Presentation of the Draft Consensus Statement
9:30 a.m. Discussion
11:00 a.m. Adjournment
2:00 p.m. Press Telebriefing